Introduction
The tumor suppressor p53, known best as the Guardian of the Genome, is also known for its tactical role in assuring genomic stability of the cell by recognizing DNA damage and ultimately deciding cellular fate. P53 acts primarily as a transcriptional activator that regulates the expression of several genes involved in cellular senescence, cell cycle arrest and apoptosis (Levine, 1997; Vogelstein et al., 2000) . Activation of p53 is through stabilization of the protein and its accumulation in the cell's nucleus. In addition, the protein undergoes a number of post-translational modifications such as acetylation and phosphorylation (Appella and Anderson, 2001) .
Wild-type p53 is a structurally flexible protein and during cell division it assumes discrete conformations. Hupp et al. (1992) showed that p53's conformation also regulates its DNA-binding activity. Under no-stress conditions, p53 is present in cells in a latent or inactive form, unable to bind DNA. However, as the allosteric model (Hupp and Lane, 1994 ) predicts a switch between the inactive and active conformations of the p53 through repositioning of the C-terminus of the protein can activate DNA-binding activity of p53's core domain. Interestingly, different conformations of p53 correlate with different cellular growth characteristics, with the wild-type conformation causing growth arrest and mutant conformation helping cell proliferation in cells expressing wild-type p53. Both mutated and wildtype conformations of the protein are recognized by conformation-specific monoclonal antibodies . PAb240 epitope maps to residues 213-217 of p53, PAb242 epitope maps to amino acids 18-27, PAb246 detects amino acids 86-107 whereas PAb421 detects amino acids 363-372 (Yewdell et al., 1986) .
Mutations that inactivate p53 are numerous and occur in more than 50% of all human tumors suggesting that inactivation of p53 is a key step in tumorigenesis (Bartek et al., 1990) . That p53 is a conformationally labile protein whose structure is easily disrupted is strengthened by the relationship between mutations and structure of the protein. The crystal structure of the p53 core domain bound to consensus DNA (Cho et al., 1994) has shown that the DNA-binding ability of p53 can be changed through two different mechanisms. One is a class of mutants referred to as DNA contact mutants, which causes loss of sequence-specific DNA binding without affecting the protein's secondary structure. Many such single residue changes occur in the core domain and render the mutant product unable to bind to DNA and promote transactivation (Benchimol, 2001) . Interestingly, the majority of the other mutants are classified as structural mutants because they alter the structural elements which function in the arrangement of residues that interact directly with DNA and disrupting these is predicted to inactivate p53's transactivation activity which is the main biochemical activity responsible for the tumor suppressor function of p53 (Chao et al., 2000) . For example, some cancers in which p53 protein contains no mutations yet is non-functional included neuroblastomas (Wolff et al., 2001 ) and a small proportion of breast and colon cancers (Moll et al., 1992) .
The high incidence of p53 mutations in the DNAbinding region of p53 and the analyses indicating that different mutations lead to different phenotypes suggest that mutant p53 may contribute to a more aggressive tumor. Hence the various p53 forms can be classified according to their conformation and behavior. In the present study, we tested these predictions by adopting a genetic approach, designed to select for alterations in the pathways that lead to p53 activation. Cells expressing the temperature sensitive p53val135 (tsp53) gene, were mutagenized and cells that were resistant to the growth inhibitory properties of wild-type p53 induced by incubating at the non-permissive temperature of 321C were selected and characterized (ALTR cells). We selected and further characterized two of these lines in which the p53 was localized to the nucleus at 321C. In an effort to show a relationship between the biological activity of p53 with its conformation and form, ALTR cells were examined for potential changes in conformation and for retention of p53 function and DNA-binding activity. Our analysis suggests that p53 can exist in several alternative forms that are capable of binding DNA. Our data suggests that the form of wild-type p53 and its conformation are closely linked to transcriptional events, which may play an important role in determining cell fate.
Results

Tsp53 in the ALTR cells is nuclearly localized at 321C
Generation of the ALTR cells has been described previously. Briefly A1-5 cells, which express a tsp53, become growth arrested at 321C in a p53-dependent manner (Martinez et al., 1991) . ALTR cells were generated by mutagenizing A1-5 cells and then selecting for cells that could grow at 321C. Two cell lines, ALTR-17 and ALTR-24, were selected for further characterization. To confirm that the ALTR cells proliferate at 321C we conducted growth curves (Figure 1 ). We show that at 321C the growth rate is slow but that the cells do proliferate when compared to A1-5 cells incubated at same temperature, which are completely arrested. The growth rate of ALTR-24s was slightly greater than that of ALTR-17s. We next examined the subcellular localization of tsp53 using indirect immunofuorescence (Figure 2) . When studying the subcellular localization of tsp53 in these cells, the photomicrographs show that the tsp53 in both ALTR-17 and ALTR-24 cells translocates from the cytoplasm at 371C and is concentrated in the nucleus at 321C, similar to what we observe in parental Non-growth arrest phenotype of the ALTR cells is not due to lack of p21WAF-1 expression It was paradoxical that the tsp53 could induce growth arrest in A1-5 cells when localized to the nucleus but not in the ALTR cells. One simple explanation is that the tsp53 in the ALTR cells was mutated and so we sequenced the p53 transcript in its entirety in both cell lines and found that it was identical to that found in the parental cell line (data not shown).
Another possibility was that the p21WAF-1 protein was either not expressed or could be defective. P21 induces cell cycle arrest by binding to and inhibiting cyclin-dependent kinase complexes; it is well known that the kinase activity of these complexes is essential for the transitions between cell cycle phases. To test this hypothesis, we measured levels of p21WAF-1 protein via Western blot ( Figure 3a ). Following temperature shift from 37 to 321C, p21 protein's level is increased in the parental A1-5 leading to cell cycle arrest. Unexpectedly, we observed that levels of p21WAF-1 increased in the ALTR-17 and ALTR-24 cell lines although expression is reduced relative to the parental A1-5s at 321C. To confirm our Western blot results, we utilized quantitative real-time polymerase chain reaction (PCR) to assess the levels of p21WAF-1 messenger RNA and compared them with glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which was used as a control (Figure 3b ). In accordance with our previous data, we observed that p21WAF-1 is induced in both cell lines at 321C, with a higher induction in ALTR-17s. Furthermore, when the p21WAF-1 gene was sequenced we found it to be wild type in both cases (data not shown).
These observations suggested two possibilities, either that the cell cycle inhibitory pathway downstream of p21WAF-1 was non-functional or that the level of p21WAF-1 induced by the tsp53 in the ALTR cells was insufficient to bring about growth arrest. To investigate this, all three cell lines were infected with a p21WAF-1-expressing adenovirus, next the infected cells were pulse labeled with H 3 -thymidine ( Figure 4 ). As can be seen the p21WAF-1 adenovirus caused a marked reduction in H 3 -thymidine incorporation in the A1-5 cells (371C) as well as in both ALTR cells when compared with the untreated controls and cells infected with the empty vector. This indicated that the p21 pathway downstream of the p21WAF-1 protein was in tact. Our results also implied that, although the tsp53 in the ALTR cells was capable of inducing gene expression, its transactivation function was compromised.
Conformation of p53 in ALTR cells differs from A1-5 parental cells and from each other
The secondary structure of the p53 protein is a key regulator of its performance and has been shown to control its ability to bind DNA (McLure and Lee, 1999) . Because the tsp53 in A1-5 cells is known to undergo changes in conformation and because the tsp53 in the ALTR cells appeared to be capable of inducing p53 target gene expression, we examined the conformation of the tsp53 in each of the cell lines by immunoprecipitation using a series of antibodies (PAb240, PAb246, PAb421 and PAb242) which recognize conformational epitopes on the p53 protein ( Figure 5 ). Examination of dishes and harvested at 80% confluency, and 130 mg of protein was used for Western blot analysis. B-actin was detected as a loading control. (b) Total RNA was isolated and following a reverse transcription step, real-time PCR was performed and levels of p21 transcript was measured in A1-5 at 371C (negative control) and 321C (positive control) and ALTR-17 (321C) and ALTR-24 (321C).
The data was normalized against GAPDH control and experiment repeated in triplicate.
Different forms of p53 can bind DNA F Mayelzadeh and JD Martinez parental A1-5 cells at 37 and 321C showed that, as expected, the quantity of PAb 246 þ protein increases markedly at the lower incubation temperature (Figure 5a ). Interestingly, there is a similar increase in the quantity of PAb242 þ protein and a concomitant decrease in the quantity of Pab421 þ protein in the A1-5 cells (Figure 5c and d) . Hence, the tsp53 protein exhibits distinctly different epitope availability at the two incubation temperatures. Analysis of the tsp53 protein in the ALTR lines reveals that tsp53 in these cells exhibits a different phenotype. Immunoprecipitation with each of the four antibodies was markedly reduced in the ALTR-17 cells suggesting that all of the epitopes were occluded relative to those of the tsp53 protein in A1-5 cells ( Figure 5 ). Interestingly, the protein in ALTR-24 cells showed a 246/240 ratio that was similar to that seen in the parental cells with the quantity of Pab246 þ protein increased relative to the Pab240 þ protein ( Figure 5) . Surprisingly, the quantity of Pab421 þ protein was increased relative to the quantity of Pab242 þ protein, which is exactly opposite of that seen in A1-5 cells (Figure 5c and d). Collectively these results indicate that, even though the primary sequence of the tsp53 in the ALTR cells remains the same as that in the A1-5 cells, the secondary structure differs from that seen in the parental cells which suggest that p53 exists stably in different conformations.
tsp53 differentially induces expression of P21 and MDM2 in the A1-5 and ALTR cells It has been suggested that distinct forms of the p53 protein may bind differentially to the promoters of specific p53 target genes (Gu and Roeder, 1997) . This in conjunction with our results suggesting that the tsp53 in ALTR cells existed in different forms prompted us to test whether different p53 target genes were selectively activated by the tsp53 in the ALTR cells. Binding of p53 to the consensus element can drive the transcription of reporter genes and the p53 DNA-binding element has been shown to be present in promoter regions of several genes including p21waf1/cip1 (El-Deiry et al., 1993) and the mdm2 gene (Barak et al., 1993) . We previously demonstrated that the p21WAF-1 and MDM2 response elements could be categorized into distinct classes based on their ability to bind distinct sets of tsp53 containing complexes in A1-5 cells (Martinez et al., 1997) . Hence, the p21WAF-1 and Mdm2 p53 response elements were chosen for comparison. Transient-transfection assays Different forms of p53 can bind DNA F Mayelzadeh and JD Martinez using luciferase reporter constructs containing either the p21WAF-1 or the Mdm2 p53 response elements were used to evaluate the transactivation properties of the tsp53 in the cell lines ( Figure 6 ). As expected the most robust activation of both reporters occurs in A1-5 cells incubated at 321C. Although the level of activity of the two reporters is markedly reduced in both ALTR cell lines relative to A1-5 cells at 321C, it is interesting to note that the reduction was greater for the Mdm2 reporter ( Figure 6b ) than it was for the p21 promoter ( Figure 6a) . Moreover, the tsp53 in ALTR-17 cells appeared to be more capable of activating the p21 promoter (B65% of A1-5s at 321C) than the tsp53 in ALTR-24 cells (B50% of A1-5s at 321C) ( Figure 6a ) and it is consistent with the greater induction of p21 protein in ALTR-17s (Figure 3a ) and the reduced proliferation rate of ALTR-17 cells relative to ALTR-24 cells. These results suggest that the transactivation properties of the tsp53 proteins in the two ALTR lines are different.
DNA-bound p53 can exist in different forms
Our previous experiments suggested that the tsp53 in the ALTR-17 and 24 cells existed in aberrant conformations that were still able to induce low levels of p53 target genes expression. To explore this further we used chromatin immunoprecipitation (ChIP) assay to determine whether the forms of tsp53 expressed in the ALTR cells could bind the p53 response elements of the endogenous p21WAF-1 gene in a sequence-specific manner. DNA-protein complexes were immunoprecipitated from the three cell lines with PAb 421, PAb 242, PAb246 and PAb240. Primers which amplified p53 response element number one (RE-1) in the p21 promoter (El-Deiry et al., 1993) were then used in quantitative real-time PCR to amplify the immunoprecipitated DNA ( Figure 7 ). As expected, little or no tsp53 was bound to DNA in A1-5 cells incubated at 371C. However, in A1-5 cells incubated at 321C there was a strong signal with both Pab242 and PAb246 indicating that tsp53 was bound to the p21 promoter in these cells and that it had a wild-type conformation and that the extreme N-terminus of the proteins was open (Figure 7a and d). Unexpectedly, we found that the Pab421 antibody did not detect tsp53 binding in A1-5 cells at 321C even though this antibody has strong affinity for tsp53 ( Figure 7c ) and although there is strong induction of p21 under these conditions (Figure 3 ). The only antibody that generated a signal, although weak, in the ALTR-17 cell line was PAb 246 suggesting that some of the protein in this cell line was present on the DNA in the wild-type form (Figure 7a ). The absence of signal with the remaining antibodies, suggested that none of the other epitopes detected by our antibodies were available. However in ALTR-24 cells, strong signals were generated with PAb421 and PAb246 indicating that tsp53 was bound to DNA (Figure 7c and a) , but that the epitopes available for immunoprecipitation were different from the tsp53 in the parental A1-5s and the ALTR-17 cells. Collectively, our results suggest that DNA-bound p53 can exist in a number of alternative forms.
In vivo interaction of p53 protein and its co-activator, PC4 P53 is known to interact with a variety of cofactors, which aid in its transactivation of downstream target genes. This prompted us to examine p53/coactivator interactions in ALTR 17 and ALTR 24 cell lines. We chose PC4 because it is known to interact with p53 in its C-Terminus (Barenjee et al., 2004) . Initially, we measured the levels of PC4 and p53 proteins in each of our cell lines via Western blotting and found that each protein was expressed at equal levels in all cell lines ( Figure 8a ). Next, we performed co-immunoprecipitation experiments in an attempt to determine whether PC4 interacts differently with various forms of p53 protein. Our data (Figure 8b-c 
Discussion
In this study we utilized two mutant cell lines, ALTR-17 and ALTR-24, that are resistant to the growth inhibitory effects of tsp53 to examine the relationship between p53 structure and function and found evidence that tsp53 can exist stably in different forms with different transactivation properties. Numerous in vitro and in vivo studies show that tsp53 folds into a wild-type conformation at 321C and binds DNA and induces cell cycle arrest or apoptosis. However, in the two ALTR cell lines we studied cell proliferation was not inhibited although the tsp53 was nuclearly localized at 321C. This lack of growth arrest could not be explained by a defective p21 pathway as the p21WAF-1 gene in both the ALTR lines was sequenced and found to be wildtype and expression of p21WAF-1 using a p21-adenovirus did inhibit DNA replication. Surprisingly, we found that there was significant activation of a p21WAF-1 reporter construct in both the ALTR lines indicating that the tsp53 in both lines retained some activity. Nonetheless endogenous p21 expression was reduced and the extent of activation of a p21 reporter was less than that seen in parental A1-5 cells. Hence the level of p21 expression achieved in the ALTR cells was insufficient to bring about complete growth arrest. This suggested that the function of tsp53 in the ALTR lines was compromised. However, the tsp53 proteins retain some transactivation capacity and the tsp53 in the Different forms of p53 can bind DNA F Mayelzadeh and JD Martinez ALTR-17 cells appears to have a greater capacity for induction of the p21WAF-1 reporter than does the protein in ALTR-24 cells. This is consistent with the slower growth rate of the ALTR-17 cells. Analysis of the tsp53 protein in the ALTR cell lines suggested that the conformation of these proteins was distinctly different from that observed for the protein in A1-5 cells. A trivial explanation for this aberrant secondary structure could be that the tsp53 had sustained additional mutations that affected its conformation. There is evidence in the literature indicating that some mutations can result in an improperly folded structure that inactivates p53's DNA binding and transactivation activities. However, we found no additional mutations when we sequenced the tsp53 transcript in its entirety eliminating this as a possible explanation. On the other hand when we examined the tsp53 protein with a series of antibodies we found that the protein exhibited distinctly different epitope availabilities. The PAb246 and PAb240 antibodies are well known as conformationally specific antibodies (Yewdell et al., 1986) and the PAb242 and PAb421 antibodies detect epitopes that are at the N-and C-termini, respectively. We determined that the tsp53 in the two ALTR cell lines was distinctly different via performing immunoprecipitation assays using these conformation specific antibodies. Immunoprecipitation was markedly reduced with all of the antibodies in ALTR-17 cells, however, the 246/240 immunoprecipitation profile for the tsp53 in ALTR-24 cells was similar to that seen in A1-5 cells. Therefore, it seems likely that the tsp53 in the ALTR-17 cells is conformationally aberrant even though the coding sequence is the same as in the parental A1-5 cells and the protein is concentrated in the nucleus. Interestingly, in the ALTR-17 cells no interaction with the conformation-specific antibodies was detected yet tsp53 in these cells was capable of inducing p21 gene (Figure 3) . Therefore, although the tsp53 in this cell line is aberrant it may still be capable of activating some genes. Consistent with this notion, the tsp53 protein in the ALTR-24 cells was capable of binding DNA, demonstrated by ChIP analysis, even though it exhibited an altered secondary structure (Figure 7) . Moreover, our PC4 co-immunoprecipitation data indicated that binding to tsp53 protein was drastically reduced in both ALTR cell lines compared to tsp53 in parental A1-5 cell. Hence the p53 proteins in our ALTR cells appear to have an abnormal structure and altered or reduced co-activator-binding ability.
P53 is a structurally labile transcription factor whose structure may be modified as the cell responds to genotoxic stress (Appella and Anderson, 2001) . Our results support the notion that p53 can exist in several alternative forms. It has been suggested that an activated p53's ability to stimulate different biological outcomes may be due to its selective activation of p53 target genes (Cadwell and Zambetti, 2001) . In ALTR cells these forms of p53 exist stably and therefore may account for the cellular phenotypes exhibited by these cells. It is unclear, however, whether the difference in epitope availability that we observe is due to genuine differences in secondary structure or whether it is due to the tsp53 proteins being bound to different cellular proteins in various cell lines. Nevertheless, our results suggest that even proteins with a mutant conformation retain some of the activities exhibited by the wild-type protein such as DNA binding. As these proteins were largely inactive, it opens the possibility that they could inhibit expression of the genes whose promoters they occupy.
Knowledge of the p53 status of structure-function relationship will be important for understanding how the protein's activities are regulated. As neither of the proteins in these ALTR cell lines was mutated it would seem that the aberrant structures we observed are determined by the cell. We are currently examining this and expect our ALTR cells to provide us with a deeper understanding of how p53 is regulated and its role in several signal-transduction pathways.
Materials and methods
Cell culture and antibodies A1-5 and ALTR cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) medium, containing 10% fetal bovine serum, 100 U/ml Pen/Strep (Invitrogen, Carlsbad, CA, USA) with 5% CO2. A1-5 cells were incubated at 371C unless otherwise noted, and ALTR cell lines at 321C. Antibodies specific for p53 were PAb 421, 240, 246 and 242.
Immunoprecipitation and Immunoblotting
Cells were grown on 10 cm 2 plates to 90% confluency at the appropriate temperature. Next cells were lysed and processed according to Gaitonde et al. (2000) . The antibodies used included: goat anti-PC4 polycolonal antibody (N-17) (Santa Cruz, Santa Cruz, CA, USA) and conformation specific antip53 antibodies: PAb 421, PAb 242, PAb 246 and PAb 240.
35 S-Methionine labeling and Immunoprecipitation Cells grown on 10 cm 2 plates to 90% confluency at the appropriate temperature were used to immunoprecipitate p53 using conformation-specific antibodies. Briefly, cells were labeled with 200 mCi 35 S-methionine/plate in DMEM for 1 h, after starving for 1 h with methionine-free DMEM. Cells were lysed on ice for 10 min in 1 ml lysis buffer. 30 ml of protein A-sephadex beads (Gibco BRL, Carlsbad, CA, USA) was added to the supernatant and samples rotated for 30 min at 41C. After quantitation using scintillation counter an equal amount of protein from each sample was subjected to immunoprecipitation by protein A-sepharose beads conjugated with the conformation specific anti-p53 antibodies: PAb 421, PAb 242, PAb 246 or PAb 240 (Courtesy of Dr David Lane). The beads were processed as described by Gaitonde et al. (2000) . Samples were electrophoresed on a 10% denaturing polyacrylamide gel. Vacuum dried gels were exposed to film and developed. Quantitation of 35 S-labeled p53 protein was carried out using densitometry analysis using Scion Image software.
Indirect immunofluorescence and image processing
Cells were plated on coverslips at concentration of 2 Â 10 5 cells per 60-mm plate. After incubating for 20 h at appropriate temperatures the cells were processed and analysed according to the protocol by Gaitonde et al. (2000) .
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